LIFEMD, INC. — Earnings
Most recent reported period: FY2026 (Q1) (filed for period ending 2026-03-31) · sourced from SEC EDGAR
Next earnings (estimated): Tue, June 30, 2026 — ~54 days away. Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2026-03-31 | $50M | ↓-1.4% | $-9M | ↓-4727.9% | -17.8% |
| 2025-12-31 | $7M | ↓-88.1% | $18M | — | — |
| 2025-09-30 | $60M | ↑+13.0% | $-4M | ↑+18.3% | -3.3% |
| 2025-06-30 | $63M | ↑+23.7% | $-2M | ↑+78.5% | -0.7% |
| 2025-03-31 | $51M | ↑+15.3% | $-184K | ↑+95.3% | -2.3% |
| 2024-12-31 | $60M | ↑+32.6% | — | — | — |
| 2024-09-30 | $53M | ↑+38.0% | $-5M | ↑+23.9% | -7.5% |
| 2024-06-30 | $51M | ↑+40.9% | $-8M | ↓-27.9% | -12.4% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2026 (Q1)
Revenue
$50M
↓-1.4% -$725K YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 57 quarters
margin trajectory tells the operating-leverage storyGross Margin↑+4.2pts
88.2%
Operating Margin↓-15.5pts
-17.8%
Net Margin↓-17.3pts
-17.7%
Go deeper
LFMD Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyLFMD Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics